Can mutagenicity information be useful in an integrated testing strategy (ITS) for skin sensitization?

SAR and QSAR in Environmental Research

Volumn 21, Issue 7, 2010, Pages 619-656

  Patlewicz, G ^a   Mekenyan, O ^b   Dimitrova, G ^b   Kuseva, C ^b   Todorov, M ^b   Kotov, S ^b   Stoeva, S ^b   Donner, E M ^a  

^a DUPONT COMPANY   (United States)

^b ASSEN ZLATAROV UNIVERSITY   (Bulgaria)

Author keywords

(Q)SAR; Integrated testing strategy (ITS); Mutagenicity; REACH; Sensitization; TIMES

Indexed keywords

CHEMICAL DETECTION; EXPERT SYSTEMS; PHYSIOLOGY;

(Q)SAR; CHEMICAL MECHANISM; DEVELOPMENT AND APPLICATIONS; INTEGRATED TESTING STRATEGIES; INTEGRATED TESTING STRATEGY; MUTAGENICITY; REACH; SENSITISATION; SKIN SENSITIZATION; TISSUE METABOLISM SIMULATOR;

METABOLISM;

EID: 78649761974     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/1062936X.2010.528447     Document Type: Article

References (129)

1. European Communities, Regulation (EC) No. 1907/2006 of the European Parliament and the Council of 18 December 2006 concerning the Registration, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 76/769/ EEC and Commission Directives 91/155/EEC, 93/EEC, 93/105/EC and 2000/21/EC, Off. J. Eur. L396 (2006), pp. 1-849.
2. C. Eskes and V. Zuang, Alternative (non-animal) methods for cosmetics testing: Current status and future prospects. A report prepared in the context of the 7th Amendment to the Cosmetics Directive for establishing the timetable for phasing out animal testing, Altern. Lab. Anim. 33 (2005), pp. 1-18.
3. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm (accessed 12 May 2010).
4. G. Patlewicz and A. Worth, Review of Data Sources, QSARs and Integrated Testing Strategies for Skin Sensitisation, EUR 23225 EN. (2008). Available at http://ecb.jrc.ec.europa.eu/qsar/publications/
5. I. Kimber and R.J. Dearman, What makes a chemical an allergen?, Ann. Allergy Asth. Immunol. 90 (2003), pp. 28-31.
6. D.W. Roberts and A.O. Aptula, Determinants of skin sensitisation potential, J. Appl. Toxicol. 28 (2008), pp. 377-387.
7. D.W. Roberts and G. Patlewicz, Chemistry based non-animal predictive modeling for skin sensitization, in Ecotoxicology Modeling, J. Devillers, ed., Springer, 2009, pp. 61-83.
8. J.A. Miller and E.C. Miller, Ultimate chemical carcinogens as reactive mutagenic electrophiles, in Origins of Human Cancer, H.H. Hiatt, J.D. Watson, and J.A. Winsten, eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, 1977, pp. 605-628.
9. J. Ashby and R.W. Tennant, Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP, Mutat. Res. 204 (1988), pp. 17-115.
10. J. Ashby, J. Hilton, R.J. Dearman, R.D. Callander, and I. Kimber, Mechanistic relationship among mutagenicity, skin sensitisation and skin carcinogenicity, Environ. Health Perspect. 101 (1993), pp. 62-67.
11. E.V. Warbrick, R.J. Dearman, J. Ashby, P. Schmezer, and I. Kimber, Preliminary assessment of the skin sensitizing activity of selected rodent carcinogens using the local lymph node assay, Toxicology 163 (2001), pp. 63-69.
12. R.E. Albert, Allergic contact sensitizing chemicals as environmental carcinogens, Environ. Health Perspect. 105 (1997), pp. 940-948.
13. R.E. Albert and P.S. Magee, The tumorigenicity of mutagenic contact sensitizing chemicals, Risk Analysis 20 (2000), pp. 317-325.
14. A.M. Wolfreys and D.A. Basketter, Mutagens and sensitizers - An unequal relationship?, Cutan. Ocul. Toxicol. 23 (2004), pp. 197-205.
15. O. Mekenyan, G. Patlewicz, G. Dimitrova, C. Kuseva, M. Todorov, S. Stoeva, S Kotov, and E.M. Donner, The use of genotoxicity information in the development of Integrated Testing Strategies (ITS) for skin sensitization, Chem. Res. Toxicol. 23 (2010), pp. 1519-1540.
16. O. Mekenyan, S. Dimitrov, R. Serafimova, E. Thompson, S. Kotov, N. Dimitrova, and J.D. Walker, Identification of the structural requirements for mutagenicity by incorporating molecular flexibility and metabolic activation of chemicals I: TA100 model, Chem. Res. Toxicol. 17 (2004), pp. 753-766.
17. R. Serafimova, M. Todorov, T. Pavlov, S. Kotov, E. Jacob, A. Aptula, and O. Mekenyan, Identification of the structural requirements for mutagenicity, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model, Chem. Res. Toxicol. 20 (2007), pp. 662-676.
18. O. Mekenyan, M. Todorov, R. Serafimova, S. Stoeva, A. Aptula, R. Finking, and E. Jacob, Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals, Chem. Res. Toxicol. 20 (2007), pp. 1927-1941.
19. S.D. Dimitrov, L.K. Low, G.Y. Patlewicz, P.S. Kern, G.D. Dimitrova, M.H. Comber, R.D. Phillips, J. Niemela, P.T. Bailey, and O.G. Mekenyan, Skin sensitization: Modeling based on skin metabolism simulation and formation of protein conjugates, Int. J. Toxicol. 24 (2005), pp. 189-204.
20. G. Patlewicz, S. Dimitrov, L.K. Low, P.S. Kern, G.D. Dimitrova, M.I. Comber, A.O. Aptula, R.D. Phillips, J. Niemelä, C. Madsen, E.B. Wedebye, D.W. Roberts, P.T. Bailey, and O.G. Mekenyan, TIMES-SS - A promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivity, Reg. Toxicol. Pharmacol. 48 (2007), pp. 225-239.
21. OECD, OECD Guidelines for the Testing of Chemicals. Test No. 406: Skin Sensitisation. OECD, 1992.
22. OECD, OECD Guidelines for the Testing of Chemicals. Test No. 429: Skin Sensitisation: Local Lymph Node Assay. OECD, 2002.
23. OECD, OECD Guidelines for the Testing of Chemicals. Test No. 471: Bacterial Reverse Mutation Test. OECD, 1997.
24. OECD, OECD Guidelines for the Testing of Chemicals. Test No. 473: In vitro Mammalian Chromosome Aberration Test. OECD, 1997.
25. G. Patlewicz, D.W. Roberts, and E. Uriarte, A comparison of reactivity schemes for the prediction skin sensitization potential, Chem. Res. Toxicol. 21 (2008), pp. 521-541.
26. M. Ishidate Jr, M.C. Harnois, and T. Sofuni, A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures, Mutat. Res. 195 (1988), pp. 151-213.
27. D.W. Roberts, A.O. Aptula, and G. Patlewicz, Electrophilic chemistry related to skin sensitization. Reaction mechanistic applicability domain classification for a published data set of 106 chemicals tested in the mouse local lymph node, Chem. Res. Toxicol. 20 (2007), pp. 44-60.
28. http://potency.berkeley.edu/chempages/7,12-DIMETHYLBENZ-(a)-ANTHRACENE.html
29. http://en.wikipedia.org/wiki/Benzopyrene
30. T. Watabe and T. Ishizuka, A 7-hydroxymethyl sulfate ester as an active metabolite of 7, 12- dimethylbenz[alpha]anthracene, Science, 215 (1982), pp. 403-405.
31. J.W. Flesher, J. Horn, and A.F. Lehner, 7-Sulfooxymethylbenz[a]anthracene is an ultimate electrophilic and carcinogenic form of 7-hydroxymethylbenz[a]anthracene, Biochem. Biophys. Res. Commun. 231 (1997), pp. 712-716.
32. H.A.J. Schut and E. Snyderwine, DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis, Carcinogenesis 20 (1999), pp. 353-368.
33. W.G. Humphreys, F.F. Kadlubar, and F.P. Guengerich, Mechanism of C8 alkylation of guanine residues by activated arylamines: Evidence for initial adduct formation at the N7 position, Proc. Natl. Acad. Sci. U. S. A. 89 (1992), pp. 8278-8282.
34. J. Ashby, D.A. Basketter, D. Paton, and I. Kimber, Structure activity relationships in skin sensitization using the murine local lymph node assay, Toxicology, 103 (1995), pp. 177-194.
35. P. Rydberg, A. Malmvarn, B. Paulsson, and M. Tornqvist, A Method for Specific Meausurement of Isocyanates In Vivo, IsoCyanate 2000; Available at http://www.anchem.su.se/isocyanate2000/abstracts/abs_tornqvist.html
36. K. Seel, U. Walber, B. Herbold, and R. Kopp, Chemical behavior of seven aromatic diisocyanates (toluenediisocyanates and diphenylmethanediisocyanates) under in vitro conditions in relationship to their results in the Salmonella/microsome test, Mutat. Res. 438 (1999), pp. 109-123.
37. World Health Organization, Diphenylmethane Diisocyanate (MDI), Concise International Chemical Assessment Document 27, World Health Organization, Geneva, 2000. Available at http://www.inchem.org/documents/cicads/cicads/cicad27.htm#_27ci7000
38. G. Patlewicz, D.A. Basketter, C.K. Smith, S.A. Hotchkiss, and D.W Roberts, Skin-sensitization structure-activity relationships for aldehydes, Contact Derm. 44 (2001), pp. 331-336.
39. C. Smith and S.A.M. Hotchkiss, Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms, Taylor and Francis, Philadelphia, USA, 2001.
40. G. Patlewicz, A.O. Aptula, E. Uriate, D.W. Roberts, P.S. Kern, G.F. Gerberick, C.A. Ryan, I. Kimber, R. Dearman, and D.A. Basketter, An evaluation of selected global (Q)SARs/Expert systems for the prediction of skin sensitisation potential, SAR QSAR Environ Res 18 (2007), pp. 515-541.
41. D.W. Roberts, G.Y. Patlewicz, P.S. Kern, G.F. Gerberick, I. Kimber, R.J. Dearman, C.A. Ryan, D.A. Basketter, and A.O. Aptula, Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization, Chem. Res. Toxicol. 20 (2007), pp. 1019-1030.
42. A. Bodin, M. Linnerborg, J.L. Nilsson, and A.T. Karlberg, Structure elucidation, synthesis, and contact allergenic activity of a major hydroperoxide formed at autoxidation of the ethoxylated surfactant C12E5, Chem. Res. Toxicol. 16 (2003), pp. 575-582.
43. E. Kriek, Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2- acetylaminofluorene with guanine in rat liver DNA in vivo, Cancer Res. 32 (1972), pp. 2042-2048.
44. E. Seeberg and R.P. Fuchs, Acetylaminofluorene bound to different guanines of the sequence - GGCGCC- is excised with different efficiencies by the UvrABC excision nuclease in a pattern not correlated to the potency of mutation induction, Proc. Natl. Acad. Sci. U. S. A. 87 (1990), pp. 191-194.
45. J.A. Timbrell, Principles of Biochemical Toxicology, Informa Healthcare USA, New York, 2008.
46. D.L. Stout, K. Hemminki, and F.F. Becker, Covalent binding of 2-acetylaminofluorene, 2-aminofluorene, and N-hydroxy-2-acetylaminofluorene to rat liver nuclear DNA and protein in vivo and in vitro, Cancer Res. 40 (1980), pp. 3579-3584.
47. A. Matsuoka, M. Hayashi, and M. Ishidate Jr, Chromosomal aberration test on 29 chemicals combined with S9 mix in vitro, Mutat. Res. 66 (1979), pp. 277-290.
48. F. Nesslany and D. Marzin, A micromethod for the in vitro micronucleus assay, Mutagenesis 14 (1999), pp. 403-410.
49. J.R. DeBaun, E.C. Miller, and J.A. Miller, N-hydroxy-2-acetylaminofluorene sulfotransferase: Its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver, Cancer Res. 30 (1970), pp. 577-595.
50. H.R. Gutman and J.H. Peters, The fate of 2-acetylaminofluorene and 2-aminofluorene after application to rat skin, Cancer Res. 17 (1957), pp. 167-176.
51. A. Andersen, Final report on the safety assessment of benzaldehyde, Int. J. Toxicol. 25 (2006), pp. 11-27.
52. D. Dillon, R. Combes, and E. Zeiger, The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides, Mutagenesis 13 (1998), pp. 19-26.
53. H. Greim (ed.), Occupational Toxicants: Critical Data evaluation for MAK Values and Classification of Carcinogens, Vol. 17, Wiley-VCH, 2002, pp. 13-35.
54. J.R. Kuykendall, E.J. Jarvi, B.L. Einley, and D.J. Paustenbach, DNA-protein cross-link formation in Burkitt lymphoma cells cultured with benzaldehyde and the sedative paraldehyde, Drug Chem. Toxicol. 30 (2007), pp. 1-16.
55. P. Reichardt, A. Schreiber, G. Wickmann, G. Metzner, J. Efer, and F. Raabe, Identification and quantification of in vitro adduct formation between protein reactive xenobiotics and a lysinecontaining model peptide, Environ. Toxicol. 18 (2003), pp. 29-36.
56. R.H. Zaugg, J.A. Walder, and I.M. Klotz, Schiff base adducts of hemoglobin, J. Biol. Chem. 252 (1977), pp. 8542-8548.
57. NICNAS, Agarbois, Full Public Report NA/711, November 2000.
58. A. Matsuoka, M. Hayashi, and T. Sofuni, In vitro clastogenicity of 19 organic chemicals found in contaminated water and 7 structurally related chemicals, Environ. Mutagen. Res. Commun. 20 (1998), pp. 159-165.
59. L. Constantino and J. Iley, Microsomal metabolism of N,N-diethyl-m-toluamide (DEET, DET): The extended network of metabolites, Xenobiotica 29 (1999), pp. 409-416.
60. A.M. Kligman, The identification of contact allergens by human assay. III. The maximization test. A procedure for screening and rating contact sensitizers, J. Invest. Dermatol. 47 (1966), pp. 393-409.
61. H. Tsuruta, Percutaneous absorption of organic solvents. III. On the penetration rates of hydrophobic solvents through the excised rat skin, Ind. Health 20 (1982), pp. 335-345.
62. K. Mortelmans, S. Haworth, T. Lawlor, W. Speck, B. Tainer, and E. Zeiger, Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals, Environ. Mutagen. 8 (1986), pp. 1-119.
63. Dunnick, Toxicity Studies of n-hexane, National Toxicology Program, Research Triangle Park, NC, USA, 1991.
64. W.C. Daughtrey, D.L. Putman, J. Duffy, A.I. Soiefer, C.J. Kirwin, L.N. Curcio, and T.H. Keenan, Cytogenetic studies on commercial hexane solvent, J. Appl. Toxicol. 14 (1994), pp. 161-165.
65. M. Ishidate Jr, K.F. Miura, and T. Sofuni, Chromosome aberration assays in genetic toxicology testing in vitro, Mutat. Res. 404 (1998), pp. 167-172.
66. Ü. Egeli, B. Tunca, P. Tuncel, M. Kahraman, B. Sevinir, G. Cecener, H. Batmaz, G. Akpinar, C. Cimen, T. Cangül, and R. Bilaloglu, Genotoxic, hematoxic, pathological, and biochemical effects of hexane on Swiss albino rats, Teratog. Carcinog. Mutagen. 20 (2000), pp. 329-340.
67. D.G. Graham, D.C. Anthony, K. Boekelheide, N.A. Maschmann, R.G. Richards, J.W. Wolfram, and B.R. Shaw, Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking, Toxicol. Appl. Pharmacol. 64 (1982), pp. 415-422.
68. Chipman, n-Hexane, Environmental Health Criteria 122, World Health Organization, Geneva, 1991.
69. B. Yan, A.P. DeCaprio, M. Zhu, and S. Bank, Solid-state 13C-NMR spectroscopy of adduction products of 2,5-hexanedione with ribonuclease, albumin, and rat neurofilament protein, Chem. Biol. Interact. 102 (1996), pp. 101-116.
70. D.G. Graham, V. Amarnath, W.M. Valentine, S.J. Pyle, and D.C. Anthony, Pathogenetic studies of hexane and carbon disulfide neurotoxicity, Crit. Rev. Toxicol. 25 (1995), pp. 91-112.
71. A.P. DeCaprio, E.J. Olajos, and P. Weber, Covalent binding of a neurotoxic n-hexane metabolite: Conversion of primary amines to substitute pyrrole adducts by 2,5-hexanedione, Toxicol. Appl. Pharmacol. 65 (1982), pp. 440-450.
72. O. Ueda, K. Sugihara, S. Ohta, and S. Kitamura, Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin, Drug Metab. Dispos. 23 (2005), pp. 1312-1318.
73. O. Ueda, S. Kitamura, K. Ohashi, K. Sugihara, and S. Ohta, Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin, Drug Metab. Dispos. 31 (2003), pp. 367-372.
74. W.A. Vance, Y.Y. Wang, and H.S. Okamoto, Disubstituted amino-, nitroso-, and nitrofluorenes: A physicochemical basis for structure-activity relationships in Salmonella typhimurium, Environ. Mutagen. 9 (1987), pp. 123-141.
75. R.M. Kitchin, W.E. Bechtold, and AL. Brooks, The structure-function relationships of nitrofluorenes and nitrofluorenones in the Salmonella mutagenicity and CHO sister-chromatid exchange assays, Mutat. Res. 206 (1988), pp. 367-377.
76. L. Möller, In vivo metabolism and genotoxic effects of nitrated polycyclic aromatic hydrocarbons, Environ. Health Perspect. 102 (1994), pp. 139-146.
77. A. Matsuoka, T. Sofuni, N. Miyata, and M. Ishidate Jr, Clastogenicity of 1-nitropyrene, dinitropyrenes, fluorene and mononitrofluorenes in cultured Chinese hamster cells, Mutat. Res. 259 (1991), pp. 103-110.
78. L. Möller and M. Zeisig, DNA adduct formation after oral administration of 2-nitrofluorene and N-acetyl-2-aminofluorene, analyzed by 32P-TLC and 32P-HPLC, Carcinogenesis 14 (1993), pp. 53-59.
79. X.S. Cui, L.C. Eriksson, and L. Möller, Formation and persistence of DNA adducts during and after a long-term administration of 2-nitrofluorene, Mutat. Res. 442 (1999), pp. 9-18.
80. A.S. Kalgutkar, I. Gardner, R.S. Obach, C.L. Shaffer, E. Callegari, K.R. Henne, A.E. Mutlib, D.K. Dalvie, J.S. Lee, Y. Nakai, J.P. O'Donnell, J. Boer, and S.P. Harriman, A comprehensive listing of bioactivation pathways of organic functional groups, Curr. Drug Metabol. 6 (2005), pp. 161-225.
81. I. Zwirner-Baier and H.G. Neumann, Polycyclic nitroarenes (nitro-PAHs) as biomarkers of exposure to diesel exhaust, Mutat. Res. 441 (1999), pp. 135-144.
82. R.A. Kramer, M.G. McMenamin, and M.R. Boyd, Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat, Cancer Chemother. Pharmacol. 14 (1985), pp. 150-155.
83. R.O. Pieper, Understanding and manipulating O6-methyl- guanine-DNA methyltransferase expression, Pharmacol. Ther. 74 (1997), pp. 285-297.
84. R.J. Weinkam, T.Y. Liu, and H.S. Lin, Protein mediated chemical reactions of chloroethylnitrosoureas, Chem. Biol. Interact. 31 (1980), pp. 167-177.
85. A.E. Auletta, A.G. Martz, and A.S. Parmar, Mutagenicity of nitrosourea compounds for Salmonella typhimurium, J. Natl. Cancer Inst. 60 (1978), pp. 1495-1497.
86. V.C. Shah, R.C. Vyas, and S.G. Adhvaryu, Cytogenetic effects of MeCCNU on sister chromatid exchange frequency, cellular kinetics and chromosome aberrations, Neoplasma 33 (1986), pp. 33-37.
87. R.C. Vyas, S.G. Adhvaryu, and V.C. Shah, Genotoxic effects of MeCCNU on human peripheral blood lymphocytes, Toxicol. Lett. 44 (1988), pp. 153-159.
88. A.G. Borel and F.S. Abbott, Identification of carbamoylated thiol conjugates as metabolites of the antineoplastic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, in rats and humans, Drug Metab. Dispos. 21 (1993), pp. 889-901.
89. A. Vikram, D.N. Tripathi, P. Ramarao, and G.B. Jena, Evaluation of streptozotocin genotoxicity in rats from different ages using the micronucleus assay, Regul. Toxicol. Pharmacol. 49 (2007), pp. 238-244.
90. A.D. Bolzan, E. Lacunza, and M.S. Bianchi, Effect of recombinant interferon-alpha on streptozotocin-induced chromosome aberrations and sister-chromatid exchanges in hamster cells, Toxicol. In Vitro 18 (2004), pp. 901-905.
91. D.M. Zimmer and B.K. Bhuyan, Mutagenicity of streptozotocin and several other nitrosourea compounds in Salmonella typhimurium, Mutat. Res. 40 (1976), pp. 281-288.
92. B.R. Franza Jr, N.S. Oeschger, M.P. Oeschger, and P.S. Schein, Mutagenic activity of nitrosourea antitumor agents, J. Natl. Cancer Inst. 65 (1980), pp. 149-154.
93. U. Liegibel, H. Tinwell, R.D. Callander, P. Schmezer, and J. Ashby, Clastogenicity to the mouse bone marrow of the mouse germ cell genotoxin streptozotocin, Mutagenesis 7 (1992), pp. 471-474.
94. A.D. Bolzan and M.S. Bianchi, Genotoxicity of Streptozotocin, Mutat. Res. 512 (2002), pp. 121-134.
95. M.S. Capucci, M.E. Hoffmann, M.Z. Zdzienicka, and A.T. Natarajan, Streptozotocin-induced chromosomal aberrations, SCEs and mutations in CHO-9 parental cells and in EM-C11 mutant cell line, Mutat. Res. 326 (1995), pp. 227-234.
96. N. Chinnasamy, L.J. Fairbairn, J. Laher, M.A. Willington, and J.A. Rafferty, Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells, Mutat. Res. 416 (1998), pp. 1-10.
97. P. Masiello, E.H. Karunanyake, E. Bergamini, D.J. Hearse, and G. Mellows, (14C) Streptozotocin: Its distribution and interaction with nucleic acids and proteins, Biochem. Pharmacol. 30 (1981), pp. 1907-1913.
98. R.A. Bennett and A.E Pegg, Alkylation of DNA in rat tissues following administration of streptozotocin, Cancer Res. 41 (1981), pp. 2786-2790.
99. S.L. Gerson, K. Miller, and N.A. Berger, O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells, J. Clin. Invest. 76 (1985), pp. 2106-2114.
100. M. Campagna, P. Beffy, R. Del Carratore, L. Hauri, S. Simi, S. Bonatti, and M. Simili, Diethylsulphate and methylnitrosourea affect different targets in Chinese hamster fibroblasts: Possible mechanisms of aneuploidy induction by these agents, Mutagenesis 18 (2003), pp. 405-410.
101. N. Buckley, A regioselective mechanism for mutagenesis and oncogenesis caused by alkylnitrosourea sequence-specific DNA alkylation, J. Am. Chem. Soc. 109 (1987), pp. 7918-7920.
102. Agency for Toxic Substances and Disease Registry, Toxicological Profile for 1,1- Dichloroethene, ATSDR, Atlanta, 1994.
103. EPA, Public Health Goal for 1,1-Dichloroethylene in Drinking Water, California Environmental Protection Agency, 1999.
104. Z. Zhu, S.A. Hotchkiss, A.R. Boobis, and R.J. Edwards, Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes, Biochem. Biophys. Res. Commun. 297 (2002), pp. 65-70.
105. F. Oesch, E. Fabian, B. Oesch-Bartlomowicz, C. Werner, and R. Landsiedel, Drugmetabolizing enzymes in the skin of man, rat, and pig, Drug. Metab. Rev. 39 (2007), pp. 659-698.
106. P.G. Forkert and S.M. Boyd, Differential metabolism of 1,1-dichloroethylene in livers of A/J, CD-1, and C57BL/6 mice, Drug Metab. Dispos. 29 (2001), pp. 1396-1402.
107. H. Bartsch, C. Malaveille, A. Barbin, and G. Planche, Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450-linked microsomal mono-oxygenases, Arch. Toxicol. 41 (1979), pp. 249-277.
108. B.K. Jones and D.E. Hathway, Tissue-mediated mutagenicity of vinylidene chloride in Salmonella typhimurium TA1535, Cancer Lett. 5 (1978), pp. 1-6.
109. F. Oesch, M. Protić-Sabljić, T. Friedberg, H.J. Klimisch, and H.R. Glatt, Vinylidene chloride: Changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis, Carcinogenesis 4 (1983), pp. 1031-1038.
110. M. Sawada, T. Sofuni, and M. Ishidate Jr, Cytogenetic studies on 1,1-dichloroethylene and its two isomers in mammalian cells in vitro and in vivo, Mutat. Res. 187 (1987), pp. 157-163.
111. D.B. McGregor, A.G. Brown, S. Howgate, D. McBride, C. Riach, and W.J. Caspary, Responses of the L5178Y mouse lymphoma forward mutation assay: V. Gases and vapors, Environ. Mol. Mutagen. 17 (1991), pp. 196-219.
112. M.T.D. Cronin and D.A. Basketter, A multivariate QSAR analysis of a skin sensitization database, SAR QSAR Environ Res 2 (1994), pp. 159-179.
113. S. Zinke, I. Gerner, and E. Schlede, Evaluation of a rule base for identifying contact allergens by using a regulatory database: Comparison of data on chemicals notified in the European Union with "Structural Alerts" used in the DEREK Expert System, Altern. Lab. Anim. 30 (2002), pp. 285-298.
114. K.U. Schallreuter, K.H. Schulz, and J.M. Wood, The allergenicity of quaternary ammonium compounds in guinea pigs, Environ. Health Perspect. 70 (1986), pp. 229-237.
115. Y. Pocker and L.J. Guilbert, Carbonic anhydrase catalyzed hydrolysis and decarboxylation. Kinetic studies of enzyme catalyzed decomposition of mono- and disubstituted derivatives of carbonic acid, Biochemistry 13 (1974), pp. 70-78.
116. J. Ostergaard and C. Larsen, Bioreversible derivatives of phenol. 2. Reactivity of carbonate esters with fatty acid-like structures towards hydrolysis in aqueous solutions, Molecules 12 (2007), pp. 2396-2412.
117. SIDS, Diphenyl carbonate, SIDS Initial Assessment Report for SIAM 19, 19-22 October 2004, Berlin, Germany.
118. H. Yuan, J. Huang, and C. Cao, Prediction of skin sensitization with a particle swarm optimized support vector machine, Int. J. Mol. Sci. 10 (2009), pp. 3237-3254.
119. J.C. Fishbein, Advances in Molecular Toxicology, Vol. 2, Elsevier, Amsterdam, 2008.
120. A. Mattia and A.G. Renwick, Alicyclic, alicyclic-fused and aromatic-fused ring lactones, WHO Food Additives Series 52 (2004), pp. 175-233.
121. M. Sköld, A. Börje, M. Matura, and A.T. Karlberg, Studies on the autoxidation-identifying a linalool hydroperoxide, Contact Derm. 46 (2002), pp. 267-272.
122. M. Sköld, A. Börje, E. Harambasic, and A.T. Karlberg, Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary oxidation products and the effect on skin sensitization, Chem. Res. Toxicol. 17 (2004), pp. 1697-1705.
123. C.A. Ryan, G.F. Gerberick, L.W. Cruse, D.A. Basketter, L. Lea, L. Blaikie, R.J. Dearman, E.V. Warbrick, and I. Kimber, Activity of human contact allergens in the murine local lymph node assay, Contact Derm. 43 (2000), pp. 95-102.
124. C.S. Letizia, J. Cocchiara, J. Lalko, and A.M. Api, Fragrance material review on linalool, Food Chem. Toxicol. 41 (2003), pp. 943-964.
125. M. Ishidate Jr, M.C. Harnois, and T. Sofuni, A comparative analysis of substances tested in mammalian cell cultures, Mutat. Res. 195 (1988), pp. 151-213.
126. D. Bickers, P. Calow, H. Greim, J.M. Hanifin, A.E. Rogers, J.H. Saurat, I.G. Sipes, R.L. Smith, and H. Tagami, A toxicologic and dermatologic assessment of linalool and related esters when used as fragrance ingredients, Food Chem. Toxicol. 41 (2003), pp. 919-942.
127. Y.F. Sasaki, H. Imanishi, T. Ohta, and Y. Shirasu, Modifying effects of components of plant essence on the induction of sister-chromatid exchanges in cultured Chinese hamster ovary cells, Mutat. Res. 226 (1989), pp. 103-110.
128. E. Eder, D. Henschler, and T. Neudecker, Mutagenic properties of allylic and α, β-unsaturated compounds: Consideration of alkylating mechanisms, Xenobiotica 12 (1982), pp. 831-848.
129. D. Belsito, D. Bickers, M. Bruze, P. Calow, H. Greim, J.M. Hanifin, A.E. Rogers, J.H. Saurat, I.G. Sipes, and H. Tagami, A toxicologic and dermatologic assessment of cyclic and non-cyclic terpene alcohols when used as fragrance ingredients, Food Chem. Toxicol. 46 (2008), pp. S1-S71.